Negin
Negin Amanat, Bronte AU
Patent application number | Description | Published |
---|---|---|
20110270356 | POLYMERIC ENCAPSULATION OF MEDICAL DEVICE COMPONENTS - A hermetic encapsulation and to a method of producing the same is provided. The hermetic encapsulation comprises a polymeric material disposed about a device component and has one or more plasma activated surfaces directly bonded to one another to hermetically seal the component within the material. | 11-03-2011 |
Negin Nazem, Blacksburg, VA US
Patent application number | Description | Published |
---|---|---|
20110068291 | Metallized nanotube polymer composite (MNPC) and methods for making same - A novel method to develop highly conductive functional materials which can effectively shield various electromagnetic effects (EMEs) and harmful radiations. Metallized nanotube polymer composites (MNPC) are composed of a lightweight polymer matrix, superstrong nanotubes (NT), and functional nanoparticle inclusions. MNPC is prepared by supercritical fluid infusion of various metal precursors (Au, Pt, Fe, and Ni salts), incorporated simultaneously or sequentially, into a solid NT-polymer composite followed by thermal reduction. The infused metal precursor tends to diffuse toward the nanotube surface preferentially as well as the surfaces of the NT-polymer matrix, and is reduced to form nanometer-scale metal particles or metal coatings. The conductivity of the MNPC increases with the metallization, which provides better shielding capabilities against various EMEs and radiations by reflecting and absorbing EM waves more efficiently. Furthermore, the supercritical fluid infusion process aids to improve the toughness of the composite films significantly regardless of the existence of metal. | 03-24-2011 |
Negin Shojaee, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20090098132 | COMPOSITION AND METHOD FOR TREATING LUPUS NEPHRITIS - The present invention provides novel isolated BFLP0169 polynucleotides and polypeptides encoded by the BFLP0169 polynucleotides. Also provided are the antibodies that immunospecifically bind to a BFLP0169 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the BFLP0169 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the BFLP0169 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses. | 04-16-2009 |